Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-08-28 Sale |
2024-08-30 4:16 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I L.P. Versant Voyageurs I Parallel L.P. Versant Vantage I L.P. 10% Owner |
221,600 | $6.3202 | $1,400,556 | 6,206,964 (Indirect Direct) |
View |
2022-01-03 Sale |
2022-01-05 5:16 pm |
CHINOOK THERAPEUTICS INC. | KDNY | Versant Venture Capital VII L.P. Versant Voyageurs I L.P. Versant Voyageurs I Parallel L.P. 10% Owner |
1,000,000 | $16 | $16,000,200 | 4,175,172 (Indirect Direct) |
View |
2021-08-27 Sale |
2021-08-31 7:06 pm |
CHINOOK THERAPEUTICS INC. | KDNY | Versant Venture Capital VII L.P. Versant Voyageurs I L.P. Versant Voyageurs I Parallel L.P. 10% Owner |
850,000 | $14 | $11,900,000 | 4,867,172 (Indirect Direct) |
View |
2020-11-30 Sale |
2020-12-01 7:13 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
10,393 | $33.15 | $344,513 | 6,062,813 (Indirect Direct) |
View |
2020-11-19 Sale |
2020-11-23 4:41 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
130,017 | $33.01 | $4,291,861 | 7,646,829 (Indirect Direct) |
View |
2020-11-17 Sale |
2020-11-19 9:19 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
4,730 | $33.05 | $156,349 | 7,776,846 (Indirect Direct) |
View |
2020-11-13 Sale |
2020-11-17 7:33 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
4,700 | $33.74 | $158,587 | 7,781,576 (Indirect Direct) |
View |
2020-11-12 Sale |
2020-11-13 7:47 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
15,598 | $34.15 | $532,642 | 6,937,033 (Indirect Direct) |
View |
2020-11-10 Sale |
2020-11-12 5:41 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
39,583 | $34.11 | $1,350,354 | 8,751,874 (Indirect Direct) |
View |
2020-11-06 Sale |
2020-11-10 7:24 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
9,400 | $33.08 | $310,949 | 8,791,457 (Indirect Direct) |
View |
2020-11-04 Sale |
2020-11-06 4:44 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
11,348 | $33.14 | $376,127 | 8,800,857 (Indirect Direct) |
View |
2020-10-26 Sale |
2020-10-28 5:58 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
8,903 | $33.28 | $296,293 | 8,812,205 (Indirect Direct) |
View |
2020-10-15 Sale |
2020-10-20 8:09 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
15,746 | $33.44 | $526,529 | 8,821,108 (Indirect Direct) |
View |
2020-10-13 Sale |
2020-10-15 7:22 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
17,240 | $33.3 | $574,015 | 8,836,854 (Indirect Direct) |
View |
2020-10-08 Sale |
2020-10-13 7:41 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
22,625 | $33.5 | $757,924 | 8,854,094 (Indirect Direct) |
View |
2020-10-06 Sale |
2020-10-08 7:14 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
45,926 | $33.44 | $1,535,732 | 6,056,892 (Indirect Direct) |
View |
2020-08-10 Sale |
2020-08-12 7:57 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
13,792 | $33.06 | $455,989 | 10,541,469 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion